Alexander B, Lund BC, Bernardy NC, Christopher MLD, Friedman MJ. Early discontinuation and suboptimal dosing of prazosin: a potential missed opportunity for veterans with posttraumatic stress disorder. J Clin Psychiatry. 2015;76(5):e639-44. DOI: 10.4088/JCP.14m09057. PubMed PMID: 26035198.
Schwager AL, Haack AK, Taha SA. Impaired flexibility in decision making in rats after administration of the pharmacological stressor yohimbine. Psychopharmacol (berl). 2014;231(20):3941-52. DOI: 10.1007/s00213-014-3529-y. PubMed PMID: 24647923.
Raskind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA, Warren D, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007;61(8):928-34. DOI: 10.1016/j.biopsych.2006.06.032. PubMed PMID: 17069768.
Raskind MA, Peterson K, Williams T, Hoff DJ, Hart K, Holmes H, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013;170(9):1003-10. DOI: 10.1176/appi.ajp.2013.12081133. PubMed PMID: 23846759.
Boehnlein JK, Kinzie JD. Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin. J Psychiatr Pract. 2007;13(2):72-8. DOI: 10.1097/01.pra.0000265763.79753.c1. PubMed PMID: 17414682.